Originally published on novartis.com.
From January 13th to 16th 2020, Novartis is attending the J.P Morgan Healthcare Conference in San Francisco.
This conference is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.
Novartis CEO Vas Narasimhan addressed the conference on Monday January 13, 2020.
Download the presentation (PDF 1.4 MB)
Sourcing innovation, strategically
Phil Gotwals, the Head of BD&L at NIBR, talks about his vision for the future of business development for research.
Our partnership approach to foster innovation
Discover how we approach Partnering to help accelerate the discovery and development of transformative medicines for patients worldwide.Great to be at #JPM2020 #JMP20 to kick off the year. At 08:00 PST I’ll be sharing how our Novartis strategy has come to life and our aspirations for the coming year. You can follow along here: https://t.co/8cDTXubPjo
— Vas Narasimhan (@VasNarasimhan) January 13, 2020
Why is today a unique moment in drug discovery and development? #JPM20 https://t.co/UBWKF8XcWf
— Novartis Science (@NovartisScience) January 10, 2020
Last year was a remarkable year for our science. See why we’re excited for 2020. #JPM20
— Novartis Science (@NovartisScience) January 9, 2020
